439 related articles for article (PubMed ID: 15043709)
1. Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study.
Pistolesi S; Boldrini L; Gisfredi S; De Ieso K; Camacci T; Caniglia M; Lupi G; Leocata P; Basolo F; Pingitore R; Parenti G; Fontanini G
Neuropathol Appl Neurobiol; 2004 Apr; 30(2):118-25. PubMed ID: 15043709
[TBL] [Abstract][Full Text] [Related]
2. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
3. Expression of vascular endothelial growth factor in human meningiomas and peritumoral brain areas.
Ding YS; Wang HD; Tang K; Hu ZG; Jin W; Yan W
Ann Clin Lab Sci; 2008; 38(4):344-51. PubMed ID: 18988927
[TBL] [Abstract][Full Text] [Related]
4. [Correlation between vascular endothelial growth factor and peritumoural edema in meningiomas].
Jiang Z; Zhao J
Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(16):1115-7. PubMed ID: 12425822
[TBL] [Abstract][Full Text] [Related]
5. Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches.
Preusser M; Hassler M; Birner P; Rudas M; Acker T; Plate KH; Widhalm G; Knosp E; Breitschopf H; Berger J; Marosi C
Clin Neuropathol; 2012; 31(5):352-60. PubMed ID: 22541785
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor mRNA expression and peritumoral edema in canine primary central nervous system tumors.
Dickinson PJ; Sturges BK; Higgins RJ; Roberts BN; Leutenegger CM; Bollen AW; LeCouteur RA
Vet Pathol; 2008 Mar; 45(2):131-9. PubMed ID: 18424825
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas.
Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K
Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227
[TBL] [Abstract][Full Text] [Related]
8. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.
Baldewijns MM; Thijssen VL; Van den Eynden GG; Van Laere SJ; Bluekens AM; Roskams T; van Poppel H; De Bruïne AP; Griffioen AW; Vermeulen PB
Br J Cancer; 2007 Jun; 96(12):1888-95. PubMed ID: 17505508
[TBL] [Abstract][Full Text] [Related]
9. Significance of COX-2 and VEGF expression in histopathologic grading and invasiveness of meningiomas.
Lee SH; Lee YS; Hong YG; Kang CS
APMIS; 2014 Jan; 122(1):16-24. PubMed ID: 23756256
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor A protein level and gene expression in intracranial meningiomas with brain edema.
Nassehi D; Dyrbye H; Andresen M; Thomsen C; Juhler M; Laursen H; Broholm H
APMIS; 2011 Dec; 119(12):831-43. PubMed ID: 22085359
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of vascular endothelial growth factor expression in clear cell renal cell carcinoma.
Djordjevic G; Mozetic V; Mozetic DV; Licul V; Ilijas KM; Mustac E; Oguic R; Fuckar Z; Jonjic N
Pathol Res Pract; 2007; 203(2):99-106. PubMed ID: 17270362
[TBL] [Abstract][Full Text] [Related]
12. Cell-adhesion molecules in human meningiomas: correlation with clinical and morphological data.
Figarella-Branger D; Roche PH; Daniel L; Dufour H; Bianco N; Pellissier JF
Neuropathol Appl Neurobiol; 1997 Apr; 23(2):113-22. PubMed ID: 9160896
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
[TBL] [Abstract][Full Text] [Related]
14. Correlative evidence that tumor cell-derived caveolin-1 mediates angiogenesis in meningiomas.
Barresi V; Cerasoli S; Tuccari G
Neuropathology; 2008 Oct; 28(5):472-8. PubMed ID: 18282163
[TBL] [Abstract][Full Text] [Related]
15. Microvessel density in brain tumors.
Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Papadakis N; Varakis I
Anticancer Res; 1997; 17(6D):4747-53. PubMed ID: 9494601
[TBL] [Abstract][Full Text] [Related]
16. Correlation of p63 immunoreactivity with tumor grade in meningiomas.
Rushing EJ; Olsen C; Man YG
Int J Surg Pathol; 2008 Jan; 16(1):38-42. PubMed ID: 18203782
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas.
Hirota Y; Tachibana O; Uchiyama N; Hayashi Y; Nakada M; Kita D; Watanabe T; Higashi R; Hamada J; Hayashi Y
Clin Neurol Neurosurg; 2009 Feb; 111(2):127-33. PubMed ID: 18980792
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin receptor is expressed in meningiomas and lower levels are associated with tumour recurrence.
Küster O; Simon P; Mittelbronn M; Tabatabai G; Hermann C; Strik H; Dietz K; Roser F; Meyermann R; Schittenhelm J
Neuropathol Appl Neurobiol; 2009 Dec; 35(6):555-65. PubMed ID: 19298633
[TBL] [Abstract][Full Text] [Related]
19. Increased ratio of vascular endothelial growth factor to semaphorin3A is a negative prognostic factor in human meningiomas.
Barresi V; Tuccari G
Neuropathology; 2010 Oct; 30(5):537-46. PubMed ID: 20337947
[TBL] [Abstract][Full Text] [Related]
20. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.
Ozen O; Demirhan B; Altinörs N
Clin Neuropathol; 2005; 24(5):219-24. PubMed ID: 16167545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
